Core Viewpoint - The company has established a strategic partnership with Beijing Aerospace Test Technology Research Institute for the production of hydrazine, which is recognized by China Aerospace Science and Technology Corporation for aerospace applications [1] Group 1: Company Developments - The company's subsidiary, Dongli (Nantong) Chemical Co., Ltd., is involved in the production of hydrazine, which is primarily used as a pharmaceutical intermediate and as a raw material for efficient herbicides and insecticides [1] - In 2023, the company has formed a strategic cooperation with Beijing Aerospace Test Technology Research Institute regarding hydrazine production [1] Group 2: Market and Pricing - The current production of hydrazine is not specifically indicated for aerospace fuel for satellite propulsion, but the company is exploring its applications in this area [1] - The price increase per ton of hydrazine for the current year has not been disclosed in the interaction [1]

证券日报网讯12月17日，精华制药（002349）在互动平台回答投资者提问时表示，公司如有回购计划， 将及时履行信息披露义务。现代化基地项目规模较大，公司仍在进行项目前期可行性方案论证等工作， 有进展将及时履行信息披露义务。 ...

证券日报网讯12月9日，精华制药（002349）在互动平台回答投资者提问时表示，公司中成药产品尚未 出口到欧洲美国等地。 ...

Core Viewpoint - Jinghua Pharmaceutical (002349) is currently in the process of optimizing the production process for its product Mabalosavir, and it has not yet reached the conditions necessary for commercial production and sales [1] Company Summary - The company is actively working on the process optimization of Mabalosavir [1] - As of now, the product is not ready for commercial production and sales [1]

Group 1 - The company stated that its subsidiary's product, Dioxide Five Ring, is primarily used for the synthesis of co-polymer formaldehyde, with a small portion utilized in lithium iron phosphate battery electrolyte [1] - The pricing of the product is determined based on market demand, and its production and sales volume remain stable [1]

Core Viewpoint - The company clarifies the applications and market positioning of its products, specifically the use of its Dioxolane electrolyte solvent in comparison to carbonate solvents produced by listed companies, addressing investor concerns about product demand and market recognition [2]. Group 1: Product Applications - The company's Dioxolane products are primarily used in the synthesis of co-polymer formaldehyde, with a small portion utilized in lithium iron phosphate battery electrolyte [2]. - The pricing of Dioxolane products is determined based on market demand, indicating a responsive pricing strategy [2]. Group 2: Market Performance - The production and sales volume of the Dioxolane products have remained stable, suggesting consistent demand in the market [2]. - Despite the positive outlook for carbonate solvent companies, the company faces challenges in gaining market recognition, raising questions about its sales performance [2].

每经AI快讯，有投资者在投资者互动平台提问：公司玛巴洛沙韦还在改进中，是不是意味着短期无法 投放市场？ 精华制药（002349.SZ）12月9日在投资者互动平台表示，公司玛巴洛沙韦产品工艺优化工作尚在推进 中，目前还未具备商业化生产销售的条件。 （文章来源：每日经济新闻） ...

Industry News - The China Insurance Industry Association issued a risk warning regarding the "Anwo Stock Insurance" business, stating that it is not an approved insurance product and that stock investment losses are not insurable. The platform's activities may involve illegal financial operations [6]. - Beijing's Internet Information Office and the Beijing Financial Regulatory Bureau launched a three-month campaign to address six types of online financial misconduct, focusing on misleading public information and illegal financial services [7]. - The Ministry of Industry and Information Technology and five other departments released a plan to enhance the adaptability of supply and demand for consumer goods, aiming for a significant optimization of the supply structure by 2027, with three trillion-level consumption sectors and ten hundred-billion-level consumption hotspots [7]. - The Ministry of Natural Resources announced breakthroughs in the efficient extraction of low-grade rare metals from coal, aluminum, copper, lead, and zinc ores, with significant improvements in recovery rates for various metals [7]. - The first hydrogen refueling station in China utilizing underground hydrogen storage technology has been operational for over 1500 days, supplying over 400 tons of hydrogen, marking a significant advancement in high-pressure underground hydrogen storage technology [8]. Company News - Dongwei Technology announced a significant increase in PCB plating equipment orders, driven by rapid growth in the PCB and memory sectors, with expected record-high order amounts this year [11]. - North University Pharmaceutical stated that related flu medications have not yet been produced or sold, and this will not impact the company's performance for a considerable time [12]. - *ST Dongtong disclosed that its annual reports from 2019 to 2022 contained false records and has received a notice of termination of listing [13]. - Debang Technology's largest shareholder, the National Big Fund, reduced its stake by 2% between September 11 and October 16, completing its reduction plan [13]. - Muxi Co., Ltd. plans to issue 40.1 million shares, with the initial strategic placement of 8.02 million shares, and the subscription date set for December 5, 2025 [15].

Group 1 - The company is currently focusing on the development of products such as Mabalosavir, with ongoing optimization work for its manufacturing process [1]

Group 1 - The core point of the article is that Jinghua Pharmaceutical (002349.SZ) is currently advancing the process optimization work for Mabalosavir [1] Group 2 - The company has communicated this update through an investor interaction platform [1]